scholarly journals Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients

2017 ◽  
Vol 19 (1) ◽  
Author(s):  
Maeve Mullooly ◽  
Hannah P. Yang ◽  
Roni T. Falk ◽  
Sarah J. Nyante ◽  
Renata Cora ◽  
...  

1996 ◽  
Vol 7 (6) ◽  
pp. 591-595 ◽  
Author(s):  
Zhenrong Zhu ◽  
Markku Parviainen ◽  
Satu M�nnist� ◽  
Pirjo Pietinen ◽  
Matti Eskelinen ◽  
...  




1995 ◽  
Vol 24 (2) ◽  
pp. 151-160 ◽  
Author(s):  
Z. R. Zhu ◽  
J. Ågren ◽  
S. Männistö ◽  
P. Pietinen ◽  
M. Eskelinen ◽  
...  


2011 ◽  
Vol 102 (10) ◽  
pp. 1848-1854 ◽  
Author(s):  
Naoko Honma ◽  
Shigehira Saji ◽  
Makiko Hirose ◽  
Shin-ichiro Horiguchi ◽  
Katsumasa Kuroi ◽  
...  


2003 ◽  
Vol 45 (1) ◽  
pp. 17-23 ◽  
Author(s):  
Véronique Chajès ◽  
Flore Lavillonnière ◽  
Virginie Maillard ◽  
Bruno Giraudeau ◽  
Marie-Lise Jourdan ◽  
...  


Cancers ◽  
2019 ◽  
Vol 11 (8) ◽  
pp. 1135 ◽  
Author(s):  
Jeong Won Lee ◽  
Sung Yong Kim ◽  
Hyun Ju Lee ◽  
Sun Wook Han ◽  
Jong Eun Lee ◽  
...  

The purpose of this study was to evaluate the prognostic significance of computed tomography (CT)-attenuation of tumor-adjacent breast adipose tissue for predicting recurrence-free survival (RFS) in patients with breast cancer. We retrospectively enrolled 287 breast cancer patients who underwent pretreatment 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT. From non-contrast-enhanced CT images of PET/CT, CT-attenuation values of tumor-adjacent breast adipose tissue (TAT HU) and contralateral breast adipose tissue (CAT HU) were measured. Difference (HU difference) and percent difference (HU difference %) in CT-attenuation values between TAT HU and CAT HU were calculated. The relationships of these breast adipose tissue parameters with tumor factors and RFS were assessed. TAT HU was significantly higher than CAT HU (p < 0.001). TAT HU, HU difference, and HU difference % showed significant correlations with T stage and estrogen receptor and progesterone receptor status (p < 0.05), whereas CAT HU had no significant relationships with tumor factors (p > 0.05). Patients with high TAT HU, HU difference, and HU difference % had significantly worse RFS than those with low values (p < 0.001). In multivariate analysis, TAT HU and HU difference % were significantly associated with RFS after adjusting for clinico-pathologic factors (p < 0.05). CT-attenuation of tumor-adjacent breast adipose tissue was significantly associated with RFS in patients with breast cancer. The findings seem to support the close contact between breast cancer cells and tumor-adjacent adipocytes observed with imaging studies.





2012 ◽  
Vol 64 (7) ◽  
pp. 956-963 ◽  
Author(s):  
Eugene Shim ◽  
Kyung-Jin Yeum ◽  
Guangwen Tang ◽  
Sei Hyun Ahn ◽  
Jinah Hwang ◽  
...  


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Martin C. Chang ◽  
Zohreh Eslami ◽  
Marguerite Ennis ◽  
Pamela J. Goodwin

AbstractCrown-like structures of the breast (CLS-B), defined by the clustering of macrophages (identified using CD68 immunohistochemical staining) to surround a dying adipocyte, are a sign of adipose-tissue inflammation. In human cohorts, CLS-B positively correlates with older age, obesity, dyslipidemia and higher levels of glucose, insulin, C-reactive protein and IL-6. In an existing cohort of early-stage breast cancer patients, CLS-B were identified using H&E stained histologic sections (hCLS-B), and by CD68 immunohistochemistry (CD68 + CLS-B). We examined associations of H&E and CD68-detected CLS-B with clinicopathologic features using χ2 tests, with metabolic factors using Wilcoxon rank sum tests and with disease free and overall survival using Cox regression models. hCLS-B were detected in 59 of 163 patients with slides (36.2%) and CD68 + CLS-B in 37 of 119 patients with paraffin blocks (31.1%). hCLS-B were positively correlated with higher weight (p = 0.003), BMI (p = 0.0008) and C-reactive protein (p = 0.045). CD68 + CLS-B were positively correlated with higher weight (p = 0.006), BMI p = 0.001), leptin (p = 0.034), insulin (p = 0.008) and Homeostasis Model Assessment (p = 0.027). CD68 + CLS-B were associated with poor distant disease-free with a hazard ratio (HR) of 2.81, 95% confidence interval (CI) 1.20–6.57, and overall survival with HR 3.97 (1.66–9.48), while hCLS-B were not associated with either: HR for distant recurrence 0.59 (0.26–1.30); HR for death 1.04 (0.50–2.16). The presence of hCLS-B and of CD68 + CLS-B were associated with obesity; CD68 + CLS-B were associated with insulin resistance and adverse prognosis. Similar patterns were not seen for hCLS-B. Research is needed to understand the biologic basis for these differences.



Sign in / Sign up

Export Citation Format

Share Document